A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations - Concepedia

Concepedia

Publication | Open Access

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

DOI Full Paper Access

276

Citations

40

References

2006

Year

Hajime Asahina, K Yamazaki, Ichiro Kinoshita, Noriaki Sukoh, M. Harada, Hiroshi Yokouchi, Takashi Ishida, Shinji Ogura, Taro Kojima, Yasushi Okamoto,

British Journal of Cancer

References

	Year	Citations

Page 1